Patents by Inventor Andrew Tutt

Andrew Tutt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240050434
    Abstract: The present invention relates to the treatment of cancer and, in particular to the treatment of patients whose cancer expresses HORMAD1 with an agent that modulates mitotic processes, and diagnostic methods thereof.
    Type: Application
    Filed: December 9, 2021
    Publication date: February 15, 2024
    Inventors: Andrew Tutt, Callum Walker, Daniel Weekes, Jon Pines, Christopher Lord
  • Publication number: 20160160293
    Abstract: The application describes methods for screening subjects with breast cancer to determine if the breast cancer will be responsive to a breast cancer therapy including a taxane or a taxane derivative. The application also describes methods for treating subjects with breast cancer by screening them for the likelihood of the effectiveness of treating the cancer with a therapy including a taxane or a taxane derivative and administering the therapy in subjects when it is found that a taxane or a taxane derivative is likely to be effective.
    Type: Application
    Filed: December 8, 2015
    Publication date: June 9, 2016
    Inventor: Andrew Tutt